• Home |
• Contact Us |
• Sitemap

• 
  • Overview
  • Management Team
  • Board of Directors
  • Scientific Advisory Board
  • Careers
    • Current Openings
    • Benefits
• 
  • About Pathogen Inactivation
    • Conventional Blood Testing
    • International Consensus Conference on Pathogen Inactivation
  • Glossary of Terms
• 
  • How INTERCEPT Works
  • Product Pipeline
  • Commercializing The INTERCEPT System
  • The INTERCEPT Blood System
  • Case Study
• 
  • Abstracts
  • Archived Abstracts
  • Publications
  • Archived Publications
• 
  • Investor Overview
  • Corporate Governance
  • Analyst Coverage
  • Press Releases
  • Investor Events
  • Webcasts
  • Annual Reports
  • Annual Meeting
  • Stock Information
  • SEC Filings
  • Information Request
  • Investor Contacts
  • RSS Feeds
• 

Global Links Management Team

Investors

Investor Overview Corporate Governance Analyst Coverage Press Releases Investor Events Webcasts Annual Reports Annual Meeting Stock Information SEC Filings Information Request Investor Contacts RSS Feeds

Investor Contacts

Investor Relations Contact Lainie Corten Director, Global Communications & Marketing Phone: 925-288-6319 E-mail: ir@cerus.com	Corporate Counsel Cooley Godward LLP San Francisco, California Patent Counsel Morrison & Foerster LLP Palo Alto, California
Registrar and Transfer Agent Wells Fargo Bank 161 North Concord South St. Paul, Minnesota 55075 Phone: 1-800-468-9716 Fax: 651.450.4078	Auditors Ernst & Young LLP Palo Alto, California

© 2012 Cerus Corporation

• Legal |
• Privacy

Powered By Q4 Web Systems 3.5.18.3156